Dow Down0.22% Nasdaq Down0.00%

Accelerate Diagnostics, Inc. (AXDX)

-NasdaqCM
20.10 Down 0.23(1.13%) 10:15AM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
Accelerate Diagnostics, Inc.
3950 South Country Club
Suite 470
Tucson, AZ 85714
United States - Map
Phone: 520-365-3100
Fax: 520-269-6580
Website: http://www.acceleratediagnostics.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Laboratories & Research
Full Time Employees:47

Business Summary 

Accelerate Diagnostics, Inc. focuses on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel system, a rapid diagnostic platform for rapid diagnosis in life-threatening infectious pathogens. It also develops and licenses OptiChem surface coatings for use in microarraying components. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is based in Tucson, Arizona.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Accelerate Diagnostics, Inc.

Corporate Governance 
Accelerate Diagnostics, Inc.’s ISS Governance QuickScore as of Aug 1, 2014 is 7. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 4; Compensation: 8.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Lawrence Mehren , 48
Chief Exec. Officer, Pres and Director
305.00K0.00
Mr. Steve Reichling , 36
Chief Financial Officer, Chief Accounting Officer and Sec.
173.00K0.00
Mr. Pete Bantock , 48
Chief Commercial Officer
115.00K0.00
Dr. David W. Grainger Ph.D., 54
Chairman of Scientific Advisory Board and Consultant
N/AN/A
Dr. Marin H. Kollef M.D., FACP, FCCP, 57
Consultant
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders